Sunday, 20 September 2026European Markets

ACTEOS Stock Rises 9% At Session Start On Tuesday, Outperforms Market

Loading stream...

(vianews) - shares of acteos (cac 40: eos.pa) jumped 9.32% to €1.76 at 10:41 est on tuesday, after three successive sessions in a row of losses. cac 40 is rising 0.05% to €7,377.11, after two consecutive sessions in a row of gains. this seems, up until now, a somewhat positive trend trading session today.

acteos's last close was €1.61, 30% under its 52-week high of €2.30.

about acteos

acteos s.a. designs, develops, integrates, and provides software and related services in the field of supply chain management in france, germany, lebanon, and internationally. it offers acteos suite, which include forecasting and procurement system for point of sales/e-business/distribution centers; transportation management system to organize and manage transport activities; and warehouse management system, a modular solution to manage customers' warehouses. the company also provides software as a service, hotline, technical project management, and consulting services. acteos s.a. was founded in 1986 and is headquartered in roubaix, france.

earnings per share

as for profitability, acteos has a trailing twelve months eps of €0.04.

pe ratio

acteos has a trailing twelve months price to earnings ratio of 44. meaning, the purchaser of the share is investing €44 for every euro of annual earnings.

revenue growth

year-on-year quarterly revenue growth grew by 17.7%, now sitting on 14.2m for the twelve trailing months.

yearly top and bottom value

acteos's stock is valued at €1.76 at 10:41 est, way below its 52-week high of €2.30 and way higher than its 52-week low of €1.27.

more news about acteos (eos.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com